Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
62.97
+3.13 (5.23%)
Apr 24, 2025, 4:00 PM EDT - Market closed

Rhythm Pharmaceuticals Statistics

Total Valuation

RYTM has a market cap or net worth of $3.98 billion. The enterprise value is $3.77 billion.

Market Cap 3.98B
Enterprise Value 3.77B

Important Dates

The next confirmed earnings date is Wednesday, May 7, 2025, before market open.

Earnings Date May 7, 2025
Ex-Dividend Date n/a

Share Statistics

RYTM has 63.22 million shares outstanding. The number of shares has increased by 5.76% in one year.

Current Share Class 63.22M
Shares Outstanding 63.22M
Shares Change (YoY) +5.76%
Shares Change (QoQ) +0.62%
Owned by Insiders (%) 0.66%
Owned by Institutions (%) 78.85%
Float 46.96M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 29.52
Forward PS 21.08
PB Ratio 180.81
P/TBV Ratio 255.94
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 29.01
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.69.

Current Ratio 3.24
Quick Ratio 2.94
Debt / Equity 0.69
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -12.89

Financial Efficiency

Return on equity (ROE) is -155.91% and return on invested capital (ROIC) is -59.75%.

Return on Equity (ROE) -155.91%
Return on Assets (ROA) -45.78%
Return on Invested Capital (ROIC) -59.75%
Return on Capital Employed (ROCE) -95.93%
Revenue Per Employee $459,809
Profits Per Employee -$934,883
Employee Count 283
Asset Turnover 0.36
Inventory Turnover 0.98

Taxes

In the past 12 months, RYTM has paid $346,000 in taxes.

Income Tax 346,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +57.43% in the last 52 weeks. The beta is 2.32, so RYTM's price volatility has been higher than the market average.

Beta (5Y) 2.32
52-Week Price Change +57.43%
50-Day Moving Average 54.91
200-Day Moving Average 53.48
Relative Strength Index (RSI) 62.41
Average Volume (20 Days) 1,008,273

Short Selling Information

The latest short interest is 4.66 million, so 7.36% of the outstanding shares have been sold short.

Short Interest 4.66M
Short Previous Month 4.71M
Short % of Shares Out 7.36%
Short % of Float 9.92%
Short Ratio (days to cover) 8.42

Income Statement

In the last 12 months, RYTM had revenue of $130.13 million and -$264.57 million in losses. Loss per share was -$4.34.

Revenue 130.13M
Gross Profit 116.76M
Operating Income -265.50M
Pretax Income -258.09M
Net Income -264.57M
EBITDA -263.94M
EBIT -265.50M
Loss Per Share -$4.34
Full Income Statement

Balance Sheet

The company has $320.57 million in cash and $113.75 million in debt, giving a net cash position of $206.82 million or $3.27 per share.

Cash & Cash Equivalents 320.57M
Total Debt 113.75M
Net Cash 206.82M
Net Cash Per Share $3.27
Equity (Book Value) 164.55M
Book Value Per Share 0.35
Working Capital 258.68M
Full Balance Sheet

Cash Flow

Operating Cash Flow -113.88M
Capital Expenditures n/a
Free Cash Flow -113.88M
FCF Per Share -$1.80
Full Cash Flow Statement

Margins

Gross margin is 89.73%, with operating and profit margins of -204.04% and -200.27%.

Gross Margin 89.73%
Operating Margin -204.04%
Pretax Margin -200.00%
Profit Margin -200.27%
EBITDA Margin -202.83%
EBIT Margin -204.04%
FCF Margin n/a

Dividends & Yields

RYTM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.76%
Shareholder Yield -5.76%
Earnings Yield -6.65%
FCF Yield -2.86%
Dividend Details

Analyst Forecast

The average price target for RYTM is $74.92, which is 18.98% higher than the current price. The consensus rating is "Strong Buy".

Price Target $74.92
Price Target Difference 18.98%
Analyst Consensus Strong Buy
Analyst Count 12
Revenue Growth Forecast (5Y) 62.36%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RYTM has an Altman Z-Score of 2.25 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.25
Piotroski F-Score 3